|
(2S,3S)-2-[[3-(3-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(furan-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
O
H
3
C
O
O
S
N
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-2-[[3-(furan-3-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide |
Depiction based on curated SMILES
OH
N
H
O
O
H
3
C
O
O
S
N
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-N-hydroxy-3-methyl-2-[[3-(3-nitrophenyl)phenyl]sulfonylamino]pentanamide |
Depiction based on curated SMILES
OH
HN
O
_
O
O
+
N
CH
3
O
O
S
N
H
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
(2S,3S)-N-hydroxy-3-methyl-2-[[3-(4-nitrophenyl)phenyl]sulfonylamino]pentanamide |
Depiction based on curated SMILES
OH
N
H
O
_
O
O
+
N
H
3
C
O
O
S
HN
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
3-(2,5-dichlorophenyl)-N-[(2S,3S)-1-(hydroxyamino)-3-methyl-1-oxopentan-2-yl]benzamide |
Depiction based on curated SMILES
HO
NH
O
Cl
Cl
H
3
C
O
NH
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
3-(2-chlorophenyl)-N-[(2S,3S)-1-(hydroxyamino)-3-methyl-1-oxopentan-2-yl]benzamide |
Depiction based on curated SMILES
OH
HN
O
Cl
CH
3
O
HN
H
3
C
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
3-(3-chlorophenyl)-N-[(2S,3S)-1-(hydroxyamino)-3-methyl-1-oxopentan-2-yl]benzamide |
Depiction based on curated SMILES
OH
NH
O
Cl
CH
3
O
N
H
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
3-(furan-2-yl)-N-[(2S,3S)-1-(hydroxyamino)-3-methyl-1-oxopentan-2-yl]benzamide |
Depiction based on curated SMILES
HO
N
H
O
O
CH
3
O
NH
CH
3
|
Clostridium |
BoNT (Botulinum neurotoxin) |
Preclinical (in vitro) |
Thompson JC, et al. 2020. Bioorg Med Chem |
|
Guadinomine C1 |
Depiction based on curated SMILES
H
3
C
O
OH
H
H
H
3
C
H
N
N
NH
2
O
H
2
N
OH
HO
O
H
O
N
H
H
H
N
H
H
3
C
NH
H
CH
3
O
N
H
H
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Iwatsuki M, et al. 2008. J Antibiot (Tokyo) |
|
| | |